There is a continued unmet need for solutions to support people with hearing loss. The information in this report, gathered from people living with hearing loss, will be used to guide drug and technology development and inform the U.S Food and Drug Administration’s benefit-risk evaluations when reviewing technologies and therapeutics to address hearing loss.